Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Permanent Percutaneous Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation Patients: The CAPTURE Trial

VY. Reddy, P. Neuzil, T. de Potter, J. van der Heyden, SC. Tromp, B. Rensing, E. Jiresova, L. Dujka, V. Lekesova,

. 2019 ; 74 (7) : 829-839. [pub] 20190511

Jazyk angličtina Země Spojené státy americké

Typ dokumentu klinické zkoušky, časopisecké články, multicentrická studie, práce podpořená grantem, audiovizuální média

Perzistentní odkaz   https://www.medvik.cz/link/bmc20023737

BACKGROUND: Patients with high stroke risk and atrial fibrillation who are unsuitable to oral anticoagulants (OACs) require other stroke prevention strategies. A novel permanent coil filter directly placed into both common carotid arteries (CCAs) was designed to capture emboli >1.4 mm in diameter. OBJECTIVES: The multicenter, nonrandomized, first-in-human clinical CAPTURE (Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients) trial sought to determine the feasibility and safety of bilateral CCA filter placement. METHODS: Eligible patients had atrial fibrillation, CHA2DS2-VASc (Congestive heart failure, Hypertension, Age 75 years, Diabetes, Stroke/transient ischemic attack, Vascular disease, Age 65 to 74 years, Sex category) ≥2, OAC unsuitability, CCA size 4.8 to 9.8 mm, and no carotid stenosis >30%. Under ultrasound guidance, after direct transcutaneous carotid puncture with a 24-gauge needle, a motorized unit expels the filter to unfurl in the artery. Patients received aspirin/clopidogrel for 3 months, and aspirin thereafter. Primary endpoints were: 1) procedural success-bilateral, properly positioned CCA filters; and 2) 30-day incidence of major adverse events-death, stroke, major bleeding, filter migration, CCA thrombus, or stenosis. Carotid ultrasounds were conducted post-procedure, pre-discharge, at 1 week, and at 1, 3, 6, and 12 months. RESULTS: At 3 centers, 25 patients were enrolled: age 71 ± 9 years, CHA2DS2-VASc = 4.4 ± 1.0, prior embolism in 48%. Procedure success was 92% (23 of 25 patients); 1 patient had unilateral deployment. There were no device/procedure-related major adverse events; minor puncture site hematomas/edema occurred in 5 of 25 (20%). After 6-month mean follow-up, asymptomatic thrombi were detected in 4 patients (1 bilateral, 4 unilateral), adjudicated as captured (n = 3), unclassified (n = 2), or in situ (n = 0). In all patients, the thrombi dissolved with subcutaneous heparin. In 1 patient, 2 device/procedure-unrelated minor strokes occurred. CONCLUSIONS: Permanent carotid filter placement for stroke prophylaxis is technically feasible and safe. (Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients [CAPTURE]; NCT03571789).

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20023737
003      
CZ-PrNML
005      
20230116135446.0
007      
ta
008      
201125s2019 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.jacc.2019.04.035 $2 doi
035    __
$a (PubMed)31085320
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Reddy, Vivek Y $u Department of Cardiology, Homolka Hospital, Prague, Czech Republic; Department of Cardiology, Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: vivek.reddy@mountsinai.org.
245    10
$a Permanent Percutaneous Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation Patients: The CAPTURE Trial / $c VY. Reddy, P. Neuzil, T. de Potter, J. van der Heyden, SC. Tromp, B. Rensing, E. Jiresova, L. Dujka, V. Lekesova,
520    9_
$a BACKGROUND: Patients with high stroke risk and atrial fibrillation who are unsuitable to oral anticoagulants (OACs) require other stroke prevention strategies. A novel permanent coil filter directly placed into both common carotid arteries (CCAs) was designed to capture emboli >1.4 mm in diameter. OBJECTIVES: The multicenter, nonrandomized, first-in-human clinical CAPTURE (Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients) trial sought to determine the feasibility and safety of bilateral CCA filter placement. METHODS: Eligible patients had atrial fibrillation, CHA2DS2-VASc (Congestive heart failure, Hypertension, Age 75 years, Diabetes, Stroke/transient ischemic attack, Vascular disease, Age 65 to 74 years, Sex category) ≥2, OAC unsuitability, CCA size 4.8 to 9.8 mm, and no carotid stenosis >30%. Under ultrasound guidance, after direct transcutaneous carotid puncture with a 24-gauge needle, a motorized unit expels the filter to unfurl in the artery. Patients received aspirin/clopidogrel for 3 months, and aspirin thereafter. Primary endpoints were: 1) procedural success-bilateral, properly positioned CCA filters; and 2) 30-day incidence of major adverse events-death, stroke, major bleeding, filter migration, CCA thrombus, or stenosis. Carotid ultrasounds were conducted post-procedure, pre-discharge, at 1 week, and at 1, 3, 6, and 12 months. RESULTS: At 3 centers, 25 patients were enrolled: age 71 ± 9 years, CHA2DS2-VASc = 4.4 ± 1.0, prior embolism in 48%. Procedure success was 92% (23 of 25 patients); 1 patient had unilateral deployment. There were no device/procedure-related major adverse events; minor puncture site hematomas/edema occurred in 5 of 25 (20%). After 6-month mean follow-up, asymptomatic thrombi were detected in 4 patients (1 bilateral, 4 unilateral), adjudicated as captured (n = 3), unclassified (n = 2), or in situ (n = 0). In all patients, the thrombi dissolved with subcutaneous heparin. In 1 patient, 2 device/procedure-unrelated minor strokes occurred. CONCLUSIONS: Permanent carotid filter placement for stroke prophylaxis is technically feasible and safe. (Carotid Artery Implant for Trapping Upstream Emboli for Preventing Stroke in Atrial Fibrillation Patients [CAPTURE]; NCT03571789).
650    _2
$a senioři $7 D000368
650    _2
$a antikoagulancia $x terapeutické užití $7 D000925
650    _2
$a Aspirin $x terapeutické užití $7 D001241
650    _2
$a fibrilace síní $x komplikace $7 D001281
650    12
$a arteria carotis communis $x diagnostické zobrazování $7 D017536
650    _2
$a klopidogrel $x terapeutické užití $7 D000077144
650    12
$a pomůcky zabraňující embolii $7 D057505
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibrinolytika $x terapeutické užití $7 D005343
650    _2
$a heparin $x terapeutické užití $7 D006493
650    _2
$a lidé $7 D006801
650    _2
$a injekce subkutánní $7 D007279
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a inhibitory agregace trombocytů $x terapeutické užití $7 D010975
650    _2
$a primární prevence $x přístrojové vybavení $7 D011322
650    _2
$a prospektivní studie $7 D011446
650    _2
$a plicní embolie $x prevence a kontrola $7 D011655
650    _2
$a cévní mozková příhoda $x prevence a kontrola $7 D020521
650    _2
$a tromboembolie $x diagnostické zobrazování $x farmakoterapie $x prevence a kontrola $7 D013923
650    _2
$a intervenční ultrasonografie $7 D018084
655    _2
$a klinické zkoušky $7 D016430
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a práce podpořená grantem $7 D013485
655    _2
$a audiovizuální média $7 D059040
700    1_
$a Neuzil, Petr $u Department of Cardiology, Homolka Hospital, Prague, Czech Republic.
700    1_
$a de Potter, Tom $u Department of Cardiology, OLV Ziekenhuis, Aalst, Belgium.
700    1_
$a van der Heyden, Jan $u Department of Cardiology, Sint-Antonius Ziekenhuis, Nieuwegein, the Netherlands.
700    1_
$a Tromp, Selma C $u Department of Clinical Neurophysiology, Sint-Antonius Ziekenhuis, Nieuwegein, the Netherlands.
700    1_
$a Rensing, Benno $u Department of Cardiology, Sint-Antonius Ziekenhuis, Nieuwegein, the Netherlands.
700    1_
$a Jiresova, Eva $u Department of Cardiology, Homolka Hospital, Prague, Czech Republic.
700    1_
$a Dujka, Libor $u Department of Cardiology, Homolka Hospital, Prague, Czech Republic. $7 xx0280652
700    1_
$a Lekesova, Veronika $u Department of Cardiology, Homolka Hospital, Prague, Czech Republic.
773    0_
$w MED00002964 $t Journal of the American College of Cardiology $x 1558-3597 $g Roč. 74, č. 7 (2019), s. 829-839
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31085320 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20201125 $b ABA008
991    __
$a 20230116135444 $b ABA008
999    __
$a ok $b bmc $g 1596056 $s 1114413
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2019 $b 74 $c 7 $d 829-839 $e 20190511 $i 1558-3597 $m Journal of the American College of Cardiology $n J. Am. Coll. Cardiol. $x MED00002964
LZP    __
$a Pubmed-20201125

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace